Proventil HFA - (0.09 mg base per actuation)

Generic Name	Albuterol Sulfate	Innovator	Kindeva
Dosage	0.09 mg base per actuation	Branded US Sales	Less Than $1000 mn
Probable FTF	Less Than 5	Known Para IV Filers	Less Than 5
Other ANDA developers	Less Than 5	Tentative Approvals	None
Final Approvals	Less Than 5	Generic Launches	Less Than 5
Indication	PROVENTIL® HFA Inhalation Aerosol is indicated in adults and children 4 years of age and older for the treatment or prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm.
Complexities	Yes

Executive Summary

Patent Status

Launch Timelines and Competition

Company	FTF Status / 180 days exclusivity	30-Months stay	Current Litigation Status	Current Approval Status	Likelihood of launch
******	*** \ **	-**-	*** *********	********	******** ** ** ** *** **, **** / ******** **** ** *** **, ****
*****	** \ **	-**-	*** *********	********	******** ** *** **, ****

Chronology Of Events